Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Pharmapreneur - Defining a Framework for Entrepreneurship in Pharmacy Education.

Mattingly TJ 2nd, Abdelwadoud M, Mullins CD, Eddington ND.

Am J Pharm Educ. 2019 Dec;83(10):7548. doi: 10.5688/ajpe7548.

2.

An Approach to Adapting a Community-Based Cancer Control Intervention to Organizational Context.

Knott CL, Bowie J, Mullins CD, Santos SLZ, Slade J, Rosenberg E, Woodard N, Williams R, Williams RM.

Health Promot Pract. 2020 Mar;21(2):168-171. doi: 10.1177/1524839919898209. Epub 2020 Jan 20.

PMID:
31959002
3.

"I'm a Little More Trusting": Components of Trustworthiness in the Decision to Participate in Genomics Research for African Americans.

Passmore SR, Jamison AM, Hancock GR, Abdelwadoud M, Mullins CD, Rogers TB, Thomas SB.

Public Health Genomics. 2019;22(5-6):215-226. doi: 10.1159/000505271. Epub 2020 Jan 17.

PMID:
31955173
4.

Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline development.

Armstrong MJ, Gronseth GS, Gagliardi AR, Mullins CD.

Health Expect. 2019 Dec 29. doi: 10.1111/hex.13018. [Epub ahead of print]

PMID:
31884708
5.

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis.

Mattingly TJ 2nd, Slejko JF, Onukwugha E, Perfetto EM, Kottilil S, Mullins CD.

Pharmacoeconomics. 2020 Feb;38(2):233-242. doi: 10.1007/s40273-019-00864-8.

PMID:
31788751
6.

Patterns of Psychotropic Medication Use among Individuals with Traumatic Brain Injury.

Albrecht JS, Wickwire EM, Mullins CD, Rao V.

J Neurotrauma. 2019 Dec 26. doi: 10.1089/neu.2019.6580. [Epub ahead of print]

PMID:
31775590
7.

Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.

Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, de Gonzalez AB, Braunstein LZ, Bosch W, Chauhan C, Ellenberg S, Fang LC, Freedman GM, Hahn EA, Haffty BG, Khan AJ, Jimenez RB, Kesslering C, Ky B, Lee C, Lu HM, Mishra MV, Mullins CD, Mutter RW, Nagda S, Pankuch M, Powell SN, Prior FW, Schupak K, Taghian AG, Wilkinson JB, MacDonald SM, Cahlon O; RadComp (Radiotherapy Comparative Effectiveness Consortium).

BMJ Open. 2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556.

8.

Which orthopaedic trauma patients are likely to refuse to participate in a clinical trial? A latent class analysis.

O'Hara NN, Degani Y, Marvel D, Wells D, Mullins CD, Wegener S, Frey K, Joseph T, Hurst J, Castillo R, O'Toole RV; PREVENT CLOT Stakeholder Committee.

BMJ Open. 2019 Oct 11;9(10):e032631. doi: 10.1136/bmjopen-2019-032631.

9.

Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study.

Hung A, Slejko JF, Lugo A, Shaya F, Haines ST, Mullins CD.

J Manag Care Spec Pharm. 2019 Aug;25(8):913-921. doi: 10.18553/jmcp.2019.25.8.913.

10.

Modeling the Budgetary Impact of Payer Utilization Management Strategies: An Adapted Framework Based on Lessons Learned.

Hung A, Lugo A, Mullins CD.

J Manag Care Spec Pharm. 2019 Aug;25(8):922-926. doi: 10.18553/jmcp.2019.25.8.922.

11.

What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism.

Mattingly TJ 2nd, Slejko JF, Perfetto EM, Kottilil S, Mullins CD.

Patient. 2019 Dec;12(6):631-638. doi: 10.1007/s40271-019-00378-7.

PMID:
31347011
12.

Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers.

Mullins CD.

Value Health. 2019 Jul;22(7):751-753. doi: 10.1016/j.jval.2019.04.1923. Epub 2019 May 27. No abstract available.

PMID:
31277819
13.

Future of Patients in Healthcare Evaluation: The Patient-Informed Reference Case.

Slejko JF, Mattingly TJ 2nd, Mullins CD, Perfetto EM, dosReis S.

Value Health. 2019 May;22(5):545-548. doi: 10.1016/j.jval.2019.02.003.

PMID:
31104732
14.

"Back to the Future" With Value in Health.

Drummond MF, Mullins CD.

Value Health. 2019 May;22(5):503-504. doi: 10.1016/j.jval.2019.03.005. No abstract available.

PMID:
31104726
15.

A Systematic Review of Entrepreneurship in Pharmacy Practice and Education.

Mattingly TJ 2nd, Mullins CD, Melendez DR, Boyden K, Eddington ND.

Am J Pharm Educ. 2019 Apr;83(3):7233. doi: 10.5688/ajpe7233. Review.

16.

Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing.

Armstrong MJ, Gronseth GS, Day GS, Rheaume C, Alliance S, Mullins CD.

Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):246-253. doi: 10.1097/WAD.0000000000000311.

PMID:
31058683
17.

Patients' early engagement in research proposal development (PEER-PD): patients guiding the proposal writing.

Natafgi N, Tafari AT, Chauhan C, Bekelman JE, Mullins CD.

J Comp Eff Res. 2019 Apr;8(6):441-453. doi: 10.2217/cer-2018-0129. Epub 2019 Apr 5.

18.

Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.

Hung A, Mullins CD, Slejko JF, Haines ST, Shaya F, Lugo A.

J Manag Care Spec Pharm. 2019 Mar;25(3):342-349. doi: 10.18553/jmcp.2019.25.3.342.

19.

Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United States.

Sieluk J, Levy J, Sandhaus RA, Silverman H, Holm KE, Mullins CD.

Chronic Obstr Pulm Dis. 2018 Nov 8;6(1):6-16. doi: 10.15326/jcopdf.6.1.2017.0187.

20.

An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics Tool.

Onukwugha E, Jayasekera J, Gardner J, Malik S, Mullins CD, Hussain A, Ciezki JP, Reddy CA, Seal B, Valderrama A, Kwok Y.

JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00075.

21.

Study protocol testing toolkit versus usual care for implementation of screening, brief intervention, referral to treatment in hospitals: a phased cluster randomized approach.

Newhouse R, Janney M, Gilbert A, Agley J, Bakoyannis G, Ferren M, Mullins CD, Johantgen M, Schwindt R, Thoele K.

Addict Sci Clin Pract. 2018 Dec 27;13(1):28. doi: 10.1186/s13722-018-0130-4.

22.

If patients are the true north, patient-centeredness should guide research.

Schanberg LE, Mullins CD.

Nat Rev Rheumatol. 2019 Jan;15(1):5-6. doi: 10.1038/s41584-018-0129-y. No abstract available.

PMID:
30498257
23.

Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.

Levy JF, Khairnar R, Louie AV, Showalter TN, Mullins CD, Mishra MV.

Pract Radiat Oncol. 2019 Mar;9(2):e172-e179. doi: 10.1016/j.prro.2018.10.003. Epub 2018 Oct 17.

PMID:
30342180
24.

Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis.

Onukwugha E, Albarmawi H, Sun K, Mullins CD, Aly A, Hussain A.

Urol Oncol. 2018 Jul;36(7):340.e23-340.e31. doi: 10.1016/j.urolonc.2018.03.023. Epub 2018 May 1.

PMID:
29724482
25.

Emerging Good Practices for Transforming Value Assessment: Patients' Voices, Patients' Values.

Perfetto EM, Harris J, Mullins CD, dosReis S.

Value Health. 2018 Apr;21(4):386-393. doi: 10.1016/j.jval.2017.11.013. Epub 2018 Mar 8.

26.

Impact of patient involvement on clinical practice guideline development: a parallel group study.

Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR.

Implement Sci. 2018 Apr 16;13(1):55. doi: 10.1186/s13012-018-0745-6.

27.

Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.

Hussain A, Yong C, Tkaczuk KHR, Qian Y, Arellano J, Mullins CD, Onukwugha E.

PLoS One. 2018 Mar 1;13(3):e0193661. doi: 10.1371/journal.pone.0193661. eCollection 2018.

28.

Transitioning from learning healthcare systems to learning health care communities.

Mullins CD, Wingate LT, Edwards HA, Tofade T, Wutoh A.

J Comp Eff Res. 2018 Jun;7(6):603-614. doi: 10.2217/cer-2017-0105. Epub 2018 Feb 26.

29.

PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCE.

Oehrlein EM, Graff JS, Perfetto EM, Mullins CD, Dubois RW, Anyanwu C, Onukwugha E.

Int J Technol Assess Health Care. 2018 Jan;34(1):111-119. doi: 10.1017/S0266462317004408. Epub 2018 Feb 8.

PMID:
29415784
30.

College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designs.

Ross MM, Arria AM, Brown JP, Mullins CD, Schiffman J, Simoni-Wastila L, dosReis S.

Addict Behav. 2018 Apr;79:45-51. doi: 10.1016/j.addbeh.2017.12.002. Epub 2017 Dec 6.

31.

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.

Mallya UG, Boklage SH, Koren A, Delea TE, Mullins CD.

Pharmacoeconomics. 2018 Jan;36(1):115-126. doi: 10.1007/s40273-017-0590-5.

32.

Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients.

Chirikov VV, Shaya FT, Onukwugha E, Mullins CD, dosReis S, Howell CD.

Med Care. 2017 Dec;55(12):e104-e112. doi: 10.1097/MLR.0000000000000405.

PMID:
29135773
33.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE‐ISPOR Special Task Force on Real World Evidence in Health Care Decision Making.

Value Health. 2017 Sep;20(8):1009-1022. doi: 10.1016/j.jval.2017.08.3018. Epub 2017 Sep 15. Erratum in: Value Health. 2018 Feb;21(2):248.

34.

Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.

Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Mullins CD.

Value Health. 2017 Sep;20(8):1003-1008. doi: 10.1016/j.jval.2017.08.3019. Epub 2017 Sep 15.

35.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE-ISPOR Special Task Force on Real World Evidence in Health Care Decision Making.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-1032. doi: 10.1002/pds.4295. Erratum in: Pharmacoepidemiol Drug Saf. 2017 Dec;26(12 ):1570.

36.

Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Ng X, dosReis S, Beardsley R, Magder L, Mullins CD, Petri M.

Lupus. 2018 Mar;27(3):475-483. doi: 10.1177/0961203317726375. Epub 2017 Aug 31.

37.

Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment.

Haac BE, O'Hara NN, Mullins CD, Stein DM, Manson TT, Johal H, Castillo R, O'Toole RV, Slobogean GP.

BMJ Open. 2017 Aug 11;7(8):e016676. doi: 10.1136/bmjopen-2017-016676. Erratum in: BMJ Open. 2017 Dec 22;7(12 ):e016676corr1.

38.

Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What?

Mattingly TJ 2nd, Slejko JF, Mullins CD.

Ann Pharmacother. 2017 Nov;51(11):961-969. doi: 10.1177/1060028017722007. Epub 2017 Jul 17.

PMID:
28715911
39.

Perception of Barriers to the Diagnosis and Receipt of Treatment for Neuropsychiatric Disturbances After Traumatic Brain Injury.

Albrecht JS, O'Hara LM, Moser KA, Mullins CD, Rao V.

Arch Phys Med Rehabil. 2017 Dec;98(12):2548-2552. doi: 10.1016/j.apmr.2017.06.007. Epub 2017 Jul 5.

40.

Querying stakeholders to inform comparative effectiveness research.

Hong YD, Goto D, Mullins CD.

J Comp Eff Res. 2017 May 9. doi: 10.2217/cer-2016-0082. [Epub ahead of print]

41.

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.

Onukwugha E, Kwok Y, Ciezki JP, Yong C, Plaisant C, Reddy CA, Mullins CD, Seal B, Valderrama A, Hussain A.

PLoS One. 2017 Apr 18;12(4):e0175956. doi: 10.1371/journal.pone.0175956. eCollection 2017.

42.

Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis.

Goto D, Shih YT, Lecomte P, Olson M, Udeze C, Park Y, Mullins CD.

Pharmacoeconomics. 2017 Jul;35(7):685-695. doi: 10.1007/s40273-017-0505-5.

PMID:
28378193
43.

Early assessment of the 10-step patient engagement framework for patient-centred outcomes research studies: the first three steps.

Sofolahan-Oladeinde Y, Newhouse RP, Lavallee DC, Huang JC, Mullins CD.

Fam Pract. 2017 Jun 1;34(3):272-277. doi: 10.1093/fampra/cmx013.

PMID:
28334775
44.

Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients.

Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR.

PLoS One. 2017 Mar 20;12(3):e0174329. doi: 10.1371/journal.pone.0174329. eCollection 2017.

45.

Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values.

Armstrong MJ, Mullins CD.

Value Health. 2017 Feb;20(2):292-295. doi: 10.1016/j.jval.2016.11.008.

46.

Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.

Wieland LS, Berman BM, Altman DG, Barth J, Bouter LM, D'Adamo CR, Linde K, Moher D, Mullins CD, Treweek S, Tunis S, van der Windt DA, Zwarenstein M, Witt C.

J Clin Epidemiol. 2017 Apr;84:95-104. doi: 10.1016/j.jclinepi.2017.01.010. Epub 2017 Feb 7.

47.

Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer.

Onukwugha E, Yong C, Naslund M, Woods C, Mullins CD, Seal B, Hussain A.

Urol Oncol. 2017 Apr;35(4):150.e17-150.e23. doi: 10.1016/j.urolonc.2016.11.012. Epub 2016 Dec 29.

PMID:
28041997
48.

Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectives.

Mullins CD, Ernst FR, Krukas MR, Solomkin J, Eckmann C, Shelbaya A, Quintana A, Reisman A.

Clin Ther. 2016 Dec;38(12):2676-2681. doi: 10.1016/j.clinthera.2016.10.013. Epub 2016 Nov 17.

PMID:
27866659
49.

Age-related racial disparities in prostate cancer patients: A systematic review.

He T, Mullins CD.

Ethn Health. 2017 Apr;22(2):184-195. doi: 10.1080/13557858.2016.1235682. Epub 2016 Oct 5. Review.

50.

Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?

Mattingly TJ 2nd, Mullins CD, Onukwugha E.

Pharmacoeconomics. 2016 Oct;34(10):1067-70. doi: 10.1007/s40273-016-0438-4. No abstract available.

PMID:
27503564

Supplemental Content

Loading ...
Support Center